What Joimax does

Joimax GmbH is a privately-held German medical device company founded in 2001 by Wolfgang Ries in Karlsruhe, Germany, specializing in full-endoscopic and minimally invasive spinal surgery technology. The company develops and sells proprietary surgical systems, instruments, and navigation tools to hospitals and spine surgery centers worldwide through a direct enterprise sales model. Joimax operates as a German GmbH (registered HRB 109780 at Amtsgericht Mannheim) with regional offices in Karlsruhe (global headquarters), Irvine, California (North America), and Singapore (ASEAN), serving markets across EMEA, North America, and Southeast Asia. The company is family-owned and operated, with founder Wolfgang Ries's son Maximilian Ries serving as CEO and Rainer Schmitz as Managing Director; no external institutional investors or public shareholders are disclosed.

The product portfolio is organized around three primary endoscopic systems covering the major surgical approaches: TESSYS (transforaminal), iLESSYS (interlaminar, with monoportal and biportal options), and CESSYS (cervical). These core platforms are supported by an ecosystem of specialized add-on technologies including the Intracs em electromagnetic navigation system, Camsource camera heads, RoboFix magnetic holding arm, Shrill high-speed drill, Endovapor 2 radiofrequency ablation system, EndoLIF and intENTS fusion/stabilization implants, Percusys Plus percutaneous screws, Vitegra visualization, MultiZYTE pain therapy, and vertebroplasty/kyphoplasty systems (Kyverment, Versicon, Balloon Kyphoplasty). The portfolio further includes Surgical Simulators for training and a complete line of endoscopes. Joimax holds 16 registered trademarks and has accumulated peer-reviewed clinical evidence demonstrating reduced 30-day readmission rates and time-driven activity-based cost advantages versus microdiskectomy.

Joimax generates revenue primarily through hardware sales of endoscopic systems and instruments to healthcare institutions worldwide, complemented by surgeon education and training services including workshops, live surgery demonstrations, and a YouTube-hosted video hub. The company employs a direct enterprise field sales motion with regional offices and application specialists providing on-site clinical and technical support. Primary customer segments include spine and orthopedic surgeons, hospitals, and ambulatory surgery centers, with secondary patient-facing outreach through a clinic finder tool. After 25 years of continuous operation, Joimax has trained thousands of surgeons globally and positions itself as a comprehensive single-source provider across the full spectrum of endoscopic spine surgery approaches.

Name

Joimax

Legal name

joimax® GmbH

Website

https://joimax.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

Joimax is a privately-held German medical device company developing full-endoscopic minimally invasive spinal surgery systems and instruments. The company sells proprietary surgical platforms, navigation, and consumables to hospitals and spine surgery centers globally through direct enterprise field sales.

Ownership category

akta.pro rank

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Joimax generates revenue through the sale of proprietary endoscopic spine surgery systems, instruments, and equipment including endoscopes, camera systems, navigation tools, radiofrequency devices, implants, and surgical accessories. The company sells directly to hospitals and spine surgery centers worldwide through their global office network.
2. Education and Training Services: The company provides comprehensive surgeon training and education programs including workshops, educational materials, and certification, which support adoption of their surgical systems and create ongoing customer relationships.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Joimax develops, manufactures, and sells proprietary systems and instruments for full-endoscopic minimally invasive spinal surgery. Its portfolio covers transforaminal (TESSYS), interlaminar (iLESSYS), cervical (CESSYS), and pain therapy (MultiZYTE) approaches, supported by integrated navigation (Intracs em), imaging (Camsource), radiofrequency ablation (Endovapor 2), high-speed drills (Shrill), fusion implants (EndoLIF, intENTS), and stabilization/percutaneous systems (Percusys Plus, Versicon, Kyverment, Vitegra), along with surgical simulators and endoscopes.

Product overview

Joimax is a German-based medical technology company specializing in full-endoscopic and minimally invasive spinal surgery. The company offers an integrated portfolio of surgical platforms and instruments organized around three primary core systems: the TESSYS transforaminal system, iLESSYS interlaminar system (offering both monoportal and biportal access), and CESSYS cervical system. These core platforms are supported by a comprehensive ecosystem of specialized instruments and add-on technologies including the Intracs em navigation system, Camsource imaging cameras, RoboFix magnetic holding arm, Shrill drilling system, Endovapor radiofrequency ablation, and various cage and fusion products (EndoLIF, intENTS). The portfolio also includes pain therapy solutions (MultiZYTE), vertebroplasty/kyphoplasty systems (Kyverment, Balloon Kyphoplasty, Versicon), surgical simulators, and a full range of endoscopes. The company provides complete endoscopic surgical solutions spanning transforaminal, interlaminar, cervical, and pain therapy approaches, along with stabilization and VBA management procedures.

Differentiator

Problem solved

Functional benefit

Brands

• TESSYS®: Transforaminal endoscopic spine surgery system
• iLESSYS®
• CESSYS®
• MultiZYTE®
• EndoLIF®
• RoboFix®
• Intracs® em
• Camsource®
• Shrill®
• Kyverment®
• Percusys Plus®
• Vitegra®
• Versicon®
• Endovapor® 2
• intENTS®

Products and services

• TESSYS®

Quantifiable outcome

• Full-endoscopic spinal decompression or discectomy shows benefits regarding 30-day readmission rates compared to other spine surgery techniques
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature16 records

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/joimaxcom
• Facebookfacebook.com/179520555394605

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Joimax